Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-002851
Filing Date
2012-11-14
Accepted
2012-11-14 17:36:11
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC.FORM 10-Q SEPTEMBER 30, 2012 signpath10q20120930.htm 10-Q 733925
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex31-1.htm EX-31.1 16402
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN ex32-1.htm EX-32.1 9468
  Complete submission text file 0001096906-12-002851.txt   3114778

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE sppxbrl-20120930.xml EX-101.INS 513570
5 XBRL SCHEMA sppxbrl-20120930.xsd EX-101.SCH 20283
6 XBRL CALCULATION sppxbrl-20120930_cal.xml EX-101.CAL 12789
7 XBRL DEFINITION sppxbrl-20120930_def.xml EX-101.DEF 63576
8 XBRL LABEL sppxbrl-20120930_lab.xml EX-101.LAB 87719
9 XBRL PRESENTATION sppxbrl-20120930_pre.xml EX-101.PRE 86584
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 121205848
SIC: 2834 Pharmaceutical Preparations